Dr. Morepen Limited, a active public limited company, was established on 11 July 2001 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24232DL2001PLC111636. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹131.00 Cr and a paid-up capital of ₹127.25 Cr.
Formerly known as Doctor Morepen Limited. It upholds a compliant status. Employing 231 professional, Its leadership includes Varun Suri (Managing Director), Sharad Jain (Director), Ranjit Khattar (Director). Past directors included Nakka Krishnamurthy Chandrasekhar, Akshay Mehta, Varun Suri. It holds ₹8.80 M open charges and ₹10.30 Cr settled loans. Its latest AGM occurred on 06 September 2025, with the balance sheet filed on 31 March 2025. It is based at 409, Antriksh Bhawan 22, K.G. Marg, New Delhi, Delhi, 110001.
U24232DL2001PLC111636
111636
11 July 2001
₹131.00 Cr
₹127.25 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Dr. Morepen Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varun Suri | Managing Director | 11 Nov 2021 | Current |
| Sharad Jain | Director | 27 Aug 2024 | Current |
| Ranjit Khattar | Director | 12 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Aug 2007 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 11 Nov 2021 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2024 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dr. Morepen Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.83% decrease. The company also saw a substantial fall in profitability, with a 33016.41% decrease in profit. The company's net worth dipped by a decrease of 0.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Dr. Morepen had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹8,800,000.00
₹103,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 May 2015 | Bmw India Financial Services Private Limited | ₹4.40 M | Open |
| 18 May 2015 | Bmw India Financial Services Private Limited | ₹4.40 M | Open |
| 09 Aug 2006 | Lakshmi Vilas Bank Limited | ₹10.30 Cr | Satisfied |
Explore comprehensive loan charge details -
Dr. Morepen has a workforce of 231 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dr. Morepen, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Morepen's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dr. Morepen Limited last Annual general meeting of members was held on 06 Sep 2025 as per latest MCA records. was documented.
Rekha Bansal was appointed as a Cfo was appointed as a Cfo on 29 Aug 2025 & has been associated with this company since 3 months 5 days . was recorded as a recent event.
Progress on Dr. Morepen Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
Progress on Sharad Jain was appointed as a Director was appointed as a Director on 27 Aug 2024 & has been associated with this company since 1 year 3 months . was documented.
Ranjit Khattar was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.
Vipul Kumar was appointed as a Company Secretary was appointed as a Company Secretary on 07 Nov 2023 & has been associated with this company since 2 years 26 days . was recorded as a recent event.
Morepen Laboratories on Thursday said its board has approved to raise up to Rs 350 crore via issue of securities. The company's board has approved to raise fun....
The CIN of Dr. Morepen Limited is U24232DL2001PLC111636.
Dr. Morepen Limited is headquartered at 409, Antriksh Bhawan 22, K.G. Marg, New Delhi, Delhi, 110001.
Dr. Morepen Limited was incorporated on 11 July 2001.
The current directors of Dr. Morepen Limited are
The primary industry of Dr. Morepen Limited is Trade.
Dr. Morepen Limited is unlisted.
The authorized capital of Dr. Morepen Limited is ₹131.00 Cr, and the paid-up capital is ₹127.25 Cr.
The compliance status of Dr. Morepen Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX